Array BioPharma Investigative Site

Toronto, Ontario M5G 2M9

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Colorectal Cancer

Studies at this site

• Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations — Completed